Correction to: Mechanisms underlying the EEG biomarker in Dup15q syndrome.

Journal

Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222

Informations de publication

Date de publication:
Historique:
entrez: 12 11 2019
pubmed: 12 11 2019
medline: 12 11 2019
Statut: epublish

Résumé

[This corrects the article DOI: 10.1186/s13229-019-0280-6.].

Identifiants

DOI: 10.1186/s13229-019-0288-y PMID: 31709034 PMC: PMC6833208
pubmed: 31709034
doi: 10.1186/s13229-019-0288-y
pii: 288
pmc: PMC6833208
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Commentaires et corrections

Type : ErratumFor

Informations de copyright

© The Author(s). 2019.

Références

Mol Autism. 2019 Jul 3;10:29
pubmed: 31312421

Auteurs

Joel Frohlich (J)

Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
3Department of Psychology, University of California Los Angeles, 3423 Franz Hall, Los Angeles, CA 90095 USA.

Lawrence T Reiter (LT)

4Departments of Neurology, Pediatrics and Anatomy & Neurobiology, The University of Tennessee Health Science Center, 855 Monroe Ave., Link, Memphis, TN 415 USA.

Vidya Saravanapandian (V)

2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.

Charlotte DiStefano (C)

2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.

Scott Huberty (S)

2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.
5McGill University, MUHC Research Institute, 5252, boul. de Maisonneuve Ouest, 3E.19, Montreal, QC H4A 3S5 Canada.

Carly Hyde (C)

2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.

Stormy Chamberlain (S)

6Genetics and Genome Sciences, UConn Health, 400 Farmington Avenue, Farmington, CT 06030-6403 USA.

Carrie E Bearden (CE)

7Department of Psychiatry and Biobehavioral Sciences and Department of Psychology, University of California Los Angeles, Suite A7-460, 760 Westwood Plaza, Los Angeles, CA 90095 USA.

Peyman Golshani (P)

8Department of Neurology and Psychiatry, David Geffen School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095 USA.

Andrei Irimia (A)

9Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Ave., Suite 228C, Los Angeles, CA 90089 USA.

Richard W Olsen (RW)

10Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 USA.

Joerg F Hipp (JF)

Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.

Shafali S Jeste (SS)

2Center for Autism Research and Treatment, University of California Los Angeles, Semel Institute for Neuroscience, Los Angeles, CA 90024 USA.

Classifications MeSH